Research Paper Volume 13, Issue 20 pp 23810—23830
CCR5 is a prognostic biomarker and an immune regulator for triple negative breast cancer
Figure 5. Differentially expressed proteins between CCR5 high expression and low expression groups.
Figure 5. Differentially expressed proteins between CCR5 high expression and low expression groups.